Loading people...
Gretchen van Steenwyk is an Analyst at Nextech Invest in Zurich, Switzerland, where she evaluates emerging therapeutics and early-to-late-stage startup investments in the oncology sector. She brings over a decade of professional experience spanning academia, philanthropy, family offices, and venture capital, including an active affiliation with Vi Partners to scale healthtech portfolios across the Swiss and European ecosystems. During her investment career, she has provided strategic oversight by serving on the board of directors for two privately held biotechnology companies. Her extensive scientific foundation includes a Bachelor of Science and a Master of Science in Molecular Biology and Biomedical Research from the University of Queensland, followed by a doctorate in Neuroepigenetics from ETH Zürich. Van Steenwyk currently focuses on bridging complex scientific research with actionable business strategy to identify and scale transformative healthcare innovations.
Gretchen van Steenwyk serves as a dedicated Analyst at Nextech Invest, a prominent venture capital firm renowned for its strategic investments in groundbreaking technology and innovation. In her pivotal role, Gretchen is instrumental in the rigorous process of identifying, researching, and evaluating potential investment opportunities that align with Nextech Invest's forward-thinking mandate. Her analytical acumen and deep understanding of emerging market trends are crucial in pinpointing companies poised for significant growth and disruption.
At Nextech Invest, Gretchen van Steenwyk's work spans a diverse range of high-growth sectors. While the firm maintains a broad focus on transformative technologies, her efforts often concentrate on areas such as artificial intelligence, advanced biotechnology, enterprise software solutions, and sustainable technology initiatives. She is actively involved in conducting comprehensive due diligence, performing market analysis, and assessing the competitive landscape to ensure that Nextech Invest backs ventures with strong fundamentals and scalable potential. Her contributions help the firm uncover the next generation of industry leaders.
Gretchen's career trajectory reflects a strong passion for innovation and a commitment to fostering technological advancement. Prior to joining Nextech Invest, she honed her analytical skills in roles that provided exposure to both financial markets and the tech ecosystem. This background equipped her with a unique perspective on evaluating the commercial viability and long-term impact of nascent technologies. Her expertise lies in dissecting complex business models and identifying the key drivers of success for early-stage and growth-stage companies.
While specific individual investments are typically attributed to the firm's collective efforts, Gretchen van Steenwyk's analytical contributions are vital to Nextech Invest's overall portfolio development. She works closely with senior partners, providing critical insights that inform investment decisions and help shape the firm's strategic direction. Her dedication ensures that Nextech Invest continues to be a leading force in supporting visionary founders and companies that are building the future. Through her diligent research and insightful evaluations, Gretchen plays an indispensable part in Nextech Invest's mission to drive innovation and generate substantial value.
Gretchen van Steenwyk is an Analyst at Nextech Invest, a venture capital firm specializing in technology and innovation investments. She plays a key role in identifying and evaluating potential investment opportunities for the firm.
As an Analyst at Nextech Invest, Gretchen van Steenwyk contributes to investments in various high-growth technology sectors, including AI, biotech, enterprise software, and sustainable tech. Her work supports the firm's focus on disruptive innovations and early-stage companies.
Gretchen van Steenwyk works at Nextech Invest, a leading venture capital firm dedicated to funding and supporting next-generation technology companies across diverse innovative sectors.
